TCINO BIOSCIENCE

tcino-bioscience-logo

Tcino Bioscience develops molecule anti-cancer drugs for cancer patients.

#SimilarOrganizations #Financial #Website #More

TCINO BIOSCIENCE

Social Links:

Industry:
Biotechnology Medical Test And Measurement

Founded:
2020-09-02

Address:
Yongin, Ch'ungch'ong-namdo, South Korea

Country:
South Korea

Website Url:
http://www.txinno.com

Total Employee:
11+

Status:
Active

Contact:
+82 82 31 778 8688

Email Addresses:
info@txinno.com

Total Funding:
9.2 B KRW

Technology used in webpage:
South Korean Server Location


Similar Organizations

adept-biopharma-logo

Adept Biopharma

Adept Biopharma develops innovative immuno-therapeutics to help cancer patients.

enkang-pharmaceutical-technology-logo

Enkang Pharmaceutical Technology

Enkang Pharmaceutical Technology develops innovative new anti-cancer drugs and pharmaceutical products.

excelmab-logo

ExcelMab

ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.

glyconex-logo

GlycoNex

GlycoNex develops and licenses anti-cancer monoclonal antibodies.

synrx-therapeutics-logo

SynRx Therapeutics

SynRx Therapeutics develops novel anti-cancer agents.

Investors List

dayli-partners_image

Dayli Partners

Dayli Partners investment in Venture Round - Tcino Bioscience

company-k_image

Company K Partners

Company K Partners investment in Venture Round - Tcino Bioscience

korea-investment-partners_image

Korea Investment Partners

Korea Investment Partners investment in Series A - Tcino Bioscience

schmidt-4d8d_image

Schmidt

Schmidt investment in Series A - Tcino Bioscience

dsc-investment_image

DSC Investment

DSC Investment investment in Series A - Tcino Bioscience

company-k_image

Company K Partners

Company K Partners investment in Series A - Tcino Bioscience

schmidt-4d8d_image

Schmidt

Schmidt investment in Seed Round - Tcino Bioscience

korea-investment-partners_image

Korea Investment Partners

Korea Investment Partners investment in Seed Round - Tcino Bioscience

dsc-investment_image

DSC Investment

DSC Investment investment in Seed Round - Tcino Bioscience

tips-program_image

TIPS Program

TIPS Program investment in Pre Seed Round - Tcino Bioscience

Official Site Inspections

http://www.txinno.com Semrush global rank: 13.5 M Semrush visits lastest month: 78

  • Host name: 218.232.108.237
  • IP address: 218.232.108.237
  • Location: South Korea
  • Latitude: 37.5112
  • Longitude: 126.9741
  • Timezone: Asia/Seoul

Loading ...

More informations about "Tcino Bioscience"

Txinno Bioscience Inc.

Pursuing innovative treatments; Bringing hope and joy to patients and their families; A dedicated company developing novel small molecule therapies for cancerSee details»

Tcino Bioscience - Crunchbase Company Profile

Organization. Tcino Bioscience . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»

TxinnoBioscience Inc. - Medical XPRT

Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. Tcino Bioscience Co., Ltd. has secured and built core platform …See details»

Txinno

치료에 혁신을 더해; 암환자와 환자가족에게 희망과 행복을 주는; 저분자 혁신항암제 개발 전문기업See details»

Txinno Bioscience - PitchBook

Txinno Bioscience General Information Description. Operator of a biotech company designed to discover new drugs. The company secures and builds core platform technologies such as …See details»

Companext

Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. Tcino Bioscience Co., Ltd. has secured and built core platform …See details»

Txinno Bioscience Co., Ltd. - Drug pipelines, Patents, Clinical trials ...

Explore Txinno Bioscience Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Technology Platform ...See details»

TXINNO Bioscience Inc | VentureRadar

Txinno Bioscience Inc. is a dedicated company focused on developing novel small molecule therapies for cancer. By targeting the innate immune RAS pathway, Txinno aims to create …See details»

TXINNO Bioscience Inc Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for TXINNO Bioscience Inc of Yongin, Gyeonggi. Get the latest business insights from Dun & Bradstreet.See details»

TXINNO Bioscience - Overview, News & Similar companies

TXINNO Bioscience Inc is a company that operates in the Pharmaceuticals industry. It employs 11-20 people and has $1M-$5M of revenue. The company is headquartered in 상현동, 경기도, …See details»

Txinno - Company Profile - Tracxn

Txinno - Developer of therapeutics for the treatment of cancer. Raised a total funding of $8.5M over 1 round from 4 investors. Founded by Chan-Sun Park and Seongjun Kim in the year …See details»

Txinno Bioscience Inc. - VentureRadar

Similar Companies: RDP Pharma Unknown n/a RDP Pharma (RDP) is a privately held biotech, dedicated to the vision that their products will deliver valuable medicines to patients in need. …See details»

2 Key words of Txinno Bio..“Orally available STING agonist & RAS ...

Apr 12, 2021 Txinno Bio was established in September of last year. In the same year, it attracted a total of 2.55 billion won worth of investment from Schmidt, Korea Investment Partners, and …See details»

TXINNO Bioscience - Products, Competitors, Financials, Employees ...

TXINNO Bioscience specializes in the development of innovative low-molecular-weight cancer therapeutics in the biotechnology sector. The company's main offerings include targeted …See details»

Seed Round - Tcino Bioscience - 2021-07-16 - Crunchbase

Jul 16, 2021 Organization Name . Tcino Bioscience . Announced Date Jul 16, 2021; Closed On Date Jul 16, 2021; Funding Type Seed; Funding ... DSC Investment — Recent News. Edit …See details»

Txinno - Raised $8.5M Funding from 4 investors - Tracxn

Txinno has raised a total funding of $8.5M over 1 round from 4 investors. Investors include Korea Investment Holdings, DSC Investment and 2 others. Their latest funding round was of $5.95M …See details»

티씨노바이오, CFO에 임기태 상무 영입 - 바이오스펙테이터

Dec 13, 2023 티씨노바이오사이언스(Txinno Bioscience)는 최고재무관리자(CFO) 겸 경영기획본부장으로 임기태 상무를 신규 영입했다고 13일 밝혔다. 임기태 CFO는 동국대에서 …See details»

Txinno Bioscience Co., Ltd. (Txinno Bioscience Co., Ltd.) - 药物管 …

项与 Txinno Bioscience Co., Ltd. 相关的临床试验 NCT05978492 / Recruiting 临床1期 A Multicenter, Open-label, Phase 1 Dose Escalation and Expansion Study of TXN10128, an …See details»

Working at Txinno Bioscience - Glassdoor

See what employees say it's like to work at Txinno Bioscience. Salaries, reviews, and more - all posted by employees working at Txinno Bioscience.See details»

linkstock.net © 2022. All rights reserved